Host-directed drug development
Investigating potential host-directed therapeutic compounds for intracellular bacterial infections and understanding the molecular mechanisms facilitating pathogen intracellular killing. Utilizing pathogen-infected macrophages to assess bacterial burden, cellular toxicity, and the efficacy range of these compounds.
